TWISTed fibroblasts: New drivers of intestinal fibrosis in Crohn's disease
Sara Lovisa, Stefania Vetrano · 2024
Read TWISTed fibroblasts: New drivers of intestinal fibrosis in Crohn's disease by Sara Lovisa, Stefania Vetrano (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11626011.txt.
Description
Sara Lovisa and Stefania Vetrano summarize new work that names a cell type as a main driver of gut scarring in Crohn disease, in work published in 2024. Scarring narrows the gut in half or more of patients and often needs surgery, with relapse common. The cells that build scar tissue are varied and were poorly mapped.
Two recent studies agree that fibroblasts marked by two proteins are the primary scar driving population. Blocking the second protein in mice reduced scarring, and a known inhibitor of it reversed fibrosis in those models. The authors say the finding opens a path to anti scarring drugs for Crohn disease, a need that has long lacked clear targets.
Catalog record
| CREATOR | Sara Lovisa, Stefania Vetrano |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |